3
Shared Docs
3
Same-Page
6 / 3
Mentions
From: "Jeffrey E." <[email protected]> To: Richard Kahn Subjec
From: "Jeffrey E." <[email protected]> To: Richard Kahn Su
atents from yesterday's IPR decisions & MYL confirming that the third IPR decision is expected by 1-Sept, our analyst Sumant has notes out on TEVA, MYL & MNTA walking through his assumptions/thoughts. For TEVA, while today's ruling is somewhat of a setback, I'd argue that risk/reward is still positive give
<[email protected]> To: Richard Kahn Subject: Re: Add to TEVA and AGN Date: Thu, 25 Aug 2016 16:36:10 +0000 Dumb On Thursday, 25 August 2016, jeffrey E. <[email protected]> wrote: no On Thu, Aug 25, 2016 at 11:34 AM, Richard Kahn < > wrote: amanda is recommending we add to the two convertible pr
From: "Jeffrey E." <[email protected]> To: Richard Kahn Sub
atents from yesterday's IPR decisions & MYL confirming that the third IPR decision is expected by 1-Sept, our analyst Sumant has notes out on TEVA, MYL & MNTA walking through his assumptions/thoughts. For TEVA, while today's ruling is somewhat of a setback, • argue that risk/reward is still positive given
From: Richard Kahn • To: "Jeffrey E." <[email protected]> Subject: Re: Add to
h Floor New York, NY 10022 tel faxcell On Aug 25, 2016, at 12:36 PM, jeffrey E. [email protected]> wrote: Dumb On Thursday, 25 August 2016, jeffrey E. <[email protected]> wrote: no On Thu, Aug 25, 2016 at 11:34 AM, Richard Kahn • > wrote: amanda is recommending we add to the two convertible pre
atents from yesterday's IPR decisions & MYL confirming that the third IPR decision is expected by 1-Sept, our analyst Sumant has notes out on TEVA, MYL & MNTA walking through his assumptions/thoughts. For TEVA, while today's ruling is somewhat of a setback, I'd argue that risk/reward is still positive give
Entities connected to both Jeffrey Epstein and MYL & MNTA

Richard Kahn
PERSON
Marc Rich
PERSONAmanda
PERSONAmanda Ens
PERSONPierce, Fenner & Smith Incorporated
ORGANIZATIONReddy
LOCATIONSector Specialist Sales
ORGANIZATION
Mylan
ORGANIZATIONDaniel Lundquist
PERSONHealthcare Specialist Sales
ORGANIZATIONCopaxone
ORGANIZATIONSumant
ORGANIZATIONEpiPen
ORGANIZATIONCopaxone 3TW
ORGANIZATIONSandoz/NVS
ORGANIZATIONTEVVF Pfd
ORGANIZATIONMYL Note
ORGANIZATIONCopaxone 3TW Litigation
ORGANIZATIONMNTA/Sandoz
ORGANIZATIONSynthon/Pfizer
ORGANIZATION